Neuroscience
Proposed Decision Memo for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease
CMS.gov
03 July 2013
- Fda: Approval Of Alzheimer's Neuroimaging Diagnostic Drug, Vizamyl (flutemetamol F 18 Injection)
From the FDA on the 25th of October, quoting the press release: FDA approves second brain imaging drug to help evaluate patients for Alzheimer’s disease, dementia The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection),...
- Alzheimer's Disease
In Preventing Alzheimer’s, Mutation May Aid Drug Quest The New York Times By GINA KOLATA 11 July 2012 [snip] Two decades ago, researchers began discovering rare gene mutations that cause Alzheimer’s disease in all who inherit them. Now, they have...
- Alzheimer's: Impaired Beta-amyloid Clearance
From the NIH: Impaired clearance, not overproduction of toxic proteins, may underlie Alzheimer’s disease 09 December 2010 In Alzheimer's disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers...
- Early Diagnosis Of Alzheimer Disease And Fddnp
From today's New York Times: New Chemical Is Said to Provide Early Sign of Alzheimer’s Disease By REUTERS The New York Times Published: December 21, 2006 chem Originally uploaded by rissera. A chemical designed by doctors in Los Angeles...
- Medicare To Cover Pet In Diagnosis Of Some Suspected Dementias
Medicare has announced that it will begin authorizing coverage for obtaining PET scans to aid in diagnosis for patients with atypical symptoms of Alzheimer's disease or those suspected of rarer dementing diseases, such as the "fronto-temporal" dementias. ...
Neuroscience
Alzheimer's: CMS Proposed Decision Memo for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease
Proposed Decision Memo for Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease
CMS.gov
03 July 2013
Read the memo
- Fda: Approval Of Alzheimer's Neuroimaging Diagnostic Drug, Vizamyl (flutemetamol F 18 Injection)
From the FDA on the 25th of October, quoting the press release: FDA approves second brain imaging drug to help evaluate patients for Alzheimer’s disease, dementia The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection),...
- Alzheimer's Disease
In Preventing Alzheimer’s, Mutation May Aid Drug Quest The New York Times By GINA KOLATA 11 July 2012 [snip] Two decades ago, researchers began discovering rare gene mutations that cause Alzheimer’s disease in all who inherit them. Now, they have...
- Alzheimer's: Impaired Beta-amyloid Clearance
From the NIH: Impaired clearance, not overproduction of toxic proteins, may underlie Alzheimer’s disease 09 December 2010 In Alzheimer's disease, a protein fragment called beta-amyloid accumulates at abnormally high levels in the brain. Now researchers...
- Early Diagnosis Of Alzheimer Disease And Fddnp
From today's New York Times: New Chemical Is Said to Provide Early Sign of Alzheimer’s Disease By REUTERS The New York Times Published: December 21, 2006 chem Originally uploaded by rissera. A chemical designed by doctors in Los Angeles...
- Medicare To Cover Pet In Diagnosis Of Some Suspected Dementias
Medicare has announced that it will begin authorizing coverage for obtaining PET scans to aid in diagnosis for patients with atypical symptoms of Alzheimer's disease or those suspected of rarer dementing diseases, such as the "fronto-temporal" dementias. ...